Literature DB >> 24247230

Local anesthetics induce apoptosis in human breast tumor cells.

Yuan-Ching Chang1, Chien-Liang Liu, Ming-Jen Chen, Yung-Wei Hsu, Shan-Na Chen, Chi-Hsin Lin, Chin-Man Chen, Feng-Ming Yang, Meng-Chun Hu.   

Abstract

BACKGROUND: Previous studies have shown that local anesthetics may induce apoptosis in some cell types. In this study, we investigated the apoptotic effects of local anesthetics in human breast tumor cells.
METHODS: Human breast cancer (MCF-7) and mammary epithelial (MCF-10A) cell lines were treated with lidocaine and/or bupivacaine. Cell viability, DNA fragmentation, and annexin V immunofluorescence staining were assessed. The effects on apoptosis-related protein expression were investigated by Western blot analysis. The findings were extended to studies in an in vivo xenograft model.
RESULTS: Treatment of breast tumor cells with lidocaine and bupivacaine resulted in inhibition of cell viability via induction of apoptosis. The effects were more prominent in MCF-7 cells than in MCF-10A cells. Treatment with local anesthetics induced caspase 7, 8, 9, and poly ADP-ribose polymerase cleavage. The cleavage of caspase 7 and poly ADP-ribose polymerase induced by local anesthetics were effectively blocked by caspase inhibitors. Furthermore, treatment of MCF-7 xenografts with local anesthetics resulted in higher expression of cleaved caspase 7 and an increase in terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining.
CONCLUSION: Lidocaine and bupivacaine induce apoptosis of breast tumor cells at clinically relevant concentrations. Our results reveal previously unrecognized beneficial actions of local anesthetics and call for further studies to assess the oncologic advantages of their use during breast cancer surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24247230     DOI: 10.1213/ANE.0b013e3182a94479

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  48 in total

1.  Ropivacaine inhibits tumor angiogenesis via sodium-channel-independent mitochondrial dysfunction and oxidative stress.

Authors:  Jingwen Yang; Guangting Li; Kaibei Bao; Weihua Liu; Yaozhi Zhang; Weijen Ting
Journal:  J Bioenerg Biomembr       Date:  2019-03-07       Impact factor: 2.945

2.  Amide-linked local anesthetics induce apoptosis in human non-small cell lung cancer.

Authors:  Hong-Wei Wang; Le-Yi Wang; Li Jiang; Su-Ming Tian; Tai-Di Zhong; Xiang-Ming Fang
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 3.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

4.  Local anesthetics induce apoptosis in human thyroid cancer cells through the mitogen-activated protein kinase pathway.

Authors:  Yuan-Ching Chang; Yi-Chiung Hsu; Chien-Liang Liu; Shih-Yuan Huang; Meng-Chun Hu; Shih-Ping Cheng
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

5.  Lidocaine inhibits the invasion and migration of TRPV6-expressing cancer cells by TRPV6 downregulation.

Authors:  Yuan Jiang; Hui Gou; Jiang Zhu; Si Tian; Lehua Yu
Journal:  Oncol Lett       Date:  2016-06-13       Impact factor: 2.967

6.  Effect of lidocaine and ropivacaine on primary (SW480) and metastatic (SW620) colon cancer cell lines.

Authors:  Wiebke Siekmann; Elisabet Tina; Anita Koskela Von Sydow; Anil Gupta
Journal:  Oncol Lett       Date:  2019-05-07       Impact factor: 2.967

7.  Sustained Release from Ionic-Gradient Liposomes Significantly Decreases ETIDOCAINE Cytotoxicity.

Authors:  Juliana Damasceno Oliveira; Lígia Nunes de Morais Ribeiro; Gustavo Henrique Rodrigues da Silva; Bruna Renata Casadei; Verônica Muniz Couto; Elizabeth Ferreira Martinez; Eneida de Paula
Journal:  Pharm Res       Date:  2018-10-10       Impact factor: 4.200

8.  Lidocaine alleviates cytotoxicity-resistance in lung cancer A549/DDP cells via down-regulation of miR-21.

Authors:  Qing Yang; Zhi Zhang; Haixia Xu; Chuangen Ma
Journal:  Mol Cell Biochem       Date:  2019-01-14       Impact factor: 3.396

9.  Bupivacaine inhibits the malignant biological behavior of oral squamous cell carcinoma cells by inhibiting the activation of ERK1/2 and STAT3.

Authors:  Zhongchao Wang; Jie Zhang; Yongmei Wen; Pin Wang; Liyuan Fan
Journal:  Ann Transl Med       Date:  2021-05

10.  cRGDyK-modified procaine liposome inhibits the proliferation and motility of glioma cells via the ERK/p38MAPK pathway.

Authors:  Dedong Li; Jie Gao; Chenyi Yang; Bo Li; Jian Sun; Mingdong Yu; Ying Wang; Haiyun Wang; Yuechun Lu
Journal:  Exp Ther Med       Date:  2021-06-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.